ChiCTR1800014711 版本V1.0 版本创建时间2018/02/16 22:59:20 中国临床试验注册中心

审核状态:

Project audit state:

通过审核

Successful

注册号:

Registration number:

ChiCTR1800014711 

最近更新日期:

Date of Last Refreshed on:

2018-01-30 21:33:07 

注册时间:

Date of Registration:

2018-01-30 00:00:00 

注册号状态:

预注册

Registration Status:

Prospective registration

注册题目:

催眠疗法用于白内障手术中的疼痛管理

Public title:

Hypnotherapy for the management of pain in cataract surgery

注册题目简写:

English Acronym:

研究课题的正式科学名称:

催眠疗法用于白内障手术中的疼痛管理

Scientific title:

Hypnotherapy for the management of pain in cataract surgery

研究课题代号(代码):

Study subject ID:

在二级注册机构或其它机构的注册号:

The registration number of the Partner Registry or other register:

申请注册联系人:

陈春林 

研究负责人:

陈春林 

Applicant:

Chunlin Chen 

Study leader:

Chunlin Chen 

申请注册联系人电话:

Applicant telephone:

+86 13228687229

研究负责人电话:

Study leader's
telephone:

+86 13228687229

申请注册联系人传真 :

Applicant Fax:

研究负责人传真:

Study leader's fax:

申请注册联系人电子邮件:

Applicant E-mail:

chunlinc@126.com

研究负责人电子邮件:

Study leader's E-mail:

chunlinc@126.com

申请单位网址(自愿提供):

Applicant website(voluntary supply):

研究负责人网址(自愿提供):

Study leader's website(voluntary supply):

申请注册联系人通讯地址:

重庆市渝中区大坪长江支路10号

研究负责人通讯地址:

重庆市渝中区大坪长江支路10号

Applicant address:

10 Changjiang Branch Road, Chongqing, China

Study leader's address:

10 Changjiang Branch Road, Chongqing, China

申请注册联系人邮政编码:

Applicant postcode:

研究负责人邮政编码:

Study leader's postcode:

申请人所在单位:

第三军医大学大坪医院野战外科研究所眼科

Applicant's institution:

Department of Ophthalmology, Research Institute of Surgery&Daping Hospital, Third Military Medical University

研究负责人所在单位:

第三军医大学大坪医院野战外科研究所眼科

Affiliation of the Leader:

Department of Ophthalmology, Research Institute of Surgery&Daping Hospital, Third Military Medical University

是否获伦理委员会批准:

Approved by ethic committee:

Yes

伦理委员会批件文号:

Approved No. of ethic committee:

2018-01-18

伦理委员会批件附件:

Approved file of Ethical Committee:

批准本研究的伦理委员会名称:

第三军医大学大坪医院野战外科研究所伦理委员会

Name of the ethic committee:

The Ethics Committee of Research Institute of Surgery & Daping Hospital, Third Military Medical University

伦理委员会批准日期:

Date of approved by ethic committee:

2018-01-15 00:00:00

伦理委员会联系人:

范士志

Contact Name of the ethic committee:

Shizhi Fan

伦理委员会联系地址:

重庆市渝中区大坪长江支路10号

Contact Address of the ethic committee:

10 Changjiang Branch Road, Chongqing, China

伦理委员会联系人电话:

Contact phone of the ethic committee:

伦理委员会联系人邮箱:

Contact email of the ethic committee:

研究实施负责(组长)单位:

第三军医大学大坪医院野战外科研究所眼科

Primary sponsor:

Daping Hospital, Third Military Medical University

研究实施负责(组长)单位地址:

重庆市渝中区大坪长江支路10号

Primary sponsor's address:

10 Changjiang Branch Road, Chongqing, China

试验主办单位(项目批准或申办者):

Secondary sponsor:

国家:

中国

省(直辖市):

重庆

市(区县):

Country:

China

Province:

Chongqing

City:

单位(医院):

第三军医大学大坪医院

具体地址:

重庆市渝中区大坪长江支路10号

Institution
hospital:

Daping Hospital, Third Military Medical University

Address:

10 Changjiang Branch Road, Chongqing, China

经费或物资来源:

自筹

Source(s) of funding:

no

研究疾病:

白内障  

Target disease:

cataract

研究疾病代码:

Target disease code:

研究类型:

干预性研究

Study type:

Interventional study

研究所处阶段:

其它 

Study phase:

N/A

研究设计:

非随机对照试验 

Study design:

Non randomized control 

研究目的:

明确应用催眠疗法对于白内障超声乳化术中疼痛的缓解作用  

Objectives of Study:

To evaluate the efficacy of hypnotherapy in the relief of pain in phacoemulsification

药物成份或治疗方案详述:

 

Description for medicine or protocol of treatment in detail:

 

纳入标准:

1.双眼白内障患者并拟行双眼手术;2.第一眼手术VAS评分为1~3 分或>3 分

Inclusion criteria

1. bilateral cataract patients and schduled to carry out bilateral cataract surgery;
2. the VAS score were between 1 to 3 or greater than 3 for the first eye

排除标准:

第一眼术后疼痛评分1分以下;合并有幻觉、妄想、精神病或抑郁症等;嗜烟酒等

Exclusion criteria:

1. the VAS score were below 1;
2. Combined with hallucinations, delusions, psychosis, or depression;
3. smoking cigarette and drinking alchol

研究实施时间:

Study execute time:

From 2018-02-15 00:00:00 To 2018-03-15 00:00:00  

征募观察对象时间:

Recruiting time:

From 2018-02-15 00:00:00 To 2018-03-25 00:00:00

干预措施:

Interventions:

组别:

催眠治疗组

样本量:

57

Group:

hypnotherapy group one

Sample size:

干预措施:

催眠

干预措施代码:

Intervention:

hypnosis

Intervention code:

组别:

对照组

样本量:

57

Group:

Control group

Sample size:

干预措施:

None

干预措施代码:

Intervention:

None

Intervention code:

研究实施地点:

Countries of recruitment and research settings:

国家:

中国

省(直辖市):

重庆 

市(区县):

 

Country:

China

Province:

Chongqing

City:

单位(医院):

第三军医大学大坪医院 

单位级别:

三甲医院 

Institution
hospital:

Daping Hospital, Third Military Medical University

Level of the institution:

Tertiary A Hospital

国家:

中国

省(直辖市):

重庆 

市(区县):

 

Country:

China

Province:

Chongqing

City:

单位(医院):

第三军医大学新桥医院 

单位级别:

三甲医院 

Institution
hospital:

Xinqiao Hospital, Third Military Meidical University

Level of the institution:

Tertiary A Hospital

测量指标:

Outcomes:

指标中文名:

VAS评分

指标类型:

主要指标

Outcome:

VAS score

Type:

Primary indicator

测量时间点:

术后即刻

测量方法:

问卷

Measure time point of outcome:

immediately after surgery

Measure method:

questionnaire

指标中文名:

APAIS焦虑评分

指标类型:

主要指标

Outcome:

APAIS score

Type:

Primary indicator

测量时间点:

第二眼术前

测量方法:

问卷

Measure time point of outcome:

befre the second eye's surgery

Measure method:

questionnaire

指标中文名:

配合度评分

指标类型:

主要指标

Outcome:

Coordination score

Type:

Primary indicator

测量时间点:

术后即刻

测量方法:

主要指标

Measure time point of outcome:

immediately after surgery

Measure method:

questionnaire

指标中文名:

手术时长感知

指标类型:

次要指标

Outcome:

time perception of operation

Type:

Secondary indicator

测量时间点:

术后即刻

测量方法:

问卷

Measure time point of outcome:

immediately after surgery

Measure method:

questionnaire

采集人体标本:

Collecting sample(s)
from participants:

征募研究对象情况:

Recruiting status:

尚未开始

Not yet recruiting

年龄范围:

Participant age:

最小 Min age 30 years
最大 Max age 70 years

性别:

男女均可

Gender:

Both

随机方法(请说明由何人用什么方法产生随机序列):

申请注册人员采用随机数字表法产生随机序列

Randomization Procedure (please state who generates the random number sequence and by what method):

a random number table method to generate random sequences will be used by the applicant for the registration

是否公开试验完成后的统计结果:

Calculated Results after the Study Completed public access:

公开/Public

盲法:

Blinding:

试验完成后的统计结果(上传文件):

Calculated Results after
the Study Completed(upload file):

是否共享原始数据:

IPD sharing

是Yes

共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址):

2016.3.25,临床研究注册中心

The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url):

all patient's data will be uploaded on this web

数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC:

数据保存和管理采用excel进行

Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture:

Excel will be used to preserve and manage data

数据与安全监察委员会:

Data and Safety Monitoring Committee:

暂未确定/Not yet

注册人:

Name of Registration:

 2018-01-30 21:33:07